A possible role for STI571 in the treatment of idiopathic myelofibrosis

被引:1
|
作者
Hasselbalch, HC [1 ]
机构
[1] Rigshosp, Dept Hamatol L, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1002/ajh.1153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:63 / 64
页数:2
相关论文
共 50 条
  • [21] Severe periorbital edema secondary to STI571 (Gleevec)
    Esmaeli, B
    Prieto, VG
    Butler, CE
    Kim, SK
    Ahmadi, MA
    Kantarjian, HM
    Talpaz, M
    [J]. CANCER, 2002, 95 (04) : 881 - 887
  • [22] STI571 (imatinib mesylate): the tale of a targeted therapy
    Thambi, P
    Sausville, EA
    [J]. ANTI-CANCER DRUGS, 2002, 13 (02) : 111 - 114
  • [23] Does Theobromine Increase the Apoptotic Effect of STI571?
    Kasap, Yesim Korkmaz
    Ozdemir, Zeynep
    Asparuk, Cagan
    Ak, Oguzhan
    Aysun, Dide
    Akgor, Doga
    Elmastas, Fulya
    Akkus, Dogukan
    Yurtcu, Erkan
    [J]. GAZI MEDICAL JOURNAL, 2016, 27 (04): : 193 - 197
  • [24] Impact of STI571 on the pharmacokinetics of etoposide and / or ifosfamide in mice
    Decaudin, Didier
    Rezai, Keyvan
    Grandjean, Isabelle
    Weill, Sophie
    Arnaud, Philippe
    Ekue, Richard
    Garcia, Mickael
    Poupon, Marie-France
    Lokiec, Francois
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [25] Glivec/STI571 treatment stimulates megakaryopoiesis and normalizes PDGF receptor beta kinase expression in thrombocytopenic patients with myeloid metaplasia with myelofibrosis.
    le Bousse-Kerdiles, MC
    Desterke, C
    Guerton, B
    Clay, D
    Hasselbalch, H
    Gisslinger, H
    Thiele, J
    Kvasnicka, H
    Barosi, G
    [J]. BLOOD, 2005, 106 (11) : 731A - 731A
  • [26] Mice with a CML-like disease relapse with ALL under STI571 treatment
    Miething, C
    Grundler, R
    Hoepfl, J
    Mugler, C
    Gschaidmeier, H
    Peschel, C
    Duyster, J
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 96 - 96
  • [27] Imatinib mesylate (STI571; Glivec) -: a new approach in the treatment of biliary tract cancer?
    Weidmann, M
    Kreth, F
    Feisthammel, J
    Deininger, M
    Mössner, J
    Caca, K
    [J]. ANTI-CANCER DRUGS, 2003, 14 (09) : 751 - 760
  • [28] Imatinib mesilate (STI571; GleevecR):: A new approach in the treatment of bilary tract cancers?
    Wiedmann, MW
    Mössner, J
    Caca, K
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6244S - 6244S
  • [29] Effects of STI571 (gleevec) on pancreatic cancer cell growth
    Junsheng Li
    Jörg Kleeff
    Junchao Guo
    Lars Fischer
    Nathalia Giese
    Markus W Büchler
    Helmut Friess
    [J]. Molecular Cancer, 2 (1)
  • [30] STI571的研究进展及启示
    田红
    [J]. 国际输血及血液学杂志, 2001, (04) : 304 - 306